| |
|
|
|
|
|
|
|||
|
K Totpal, MM Chaturvedi, R LaPushin and BB Aggarwal
Department of Clinical Immunology and Biological Therapy, University of
Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Because retinoids are known to modulate the growth and differentiation
effects of tumor necrosis factor (TNF), we investigated the effect of
all-trans-retinoic acid (RA) on the cell surface expression of TNF
receptors in human histiocytic lymphoma U-937 cells. RA decreased the
specific binding of 125I-labeled TNF to these cells in a dose- and time-
dependent manner. The maximal decrease occurred when cells were treated
with 1 mumol/L RA for 24 hours at 37 degrees C. Scatchard analysis of the
binding indicated that the decrease by RA was caused by a decrease in
receptor number and not by a decrease in affinity. The downmodulation of
TNF receptors was also confirmed by covalent receptor- ligand cross-linking
studies. Receptor-mediated internalization of the ligand was also found to
be decreased on treatment of cells with RA. Northern blot analysis also
indicated a decrease in the transcript of the receptor. By using antibodies
specific to either the p60 or p80 form of the TNF receptor, we found that
both receptors were downregulated by RA. RA treatment also decreased TNF
receptors on acute monocytic leukemia cell line THP-1. Other analogues of
RA, specifically 9-cis-RA, (E)-4-[2-(5,6,7,8-
tetrahydro-2-naphthalenyl)-1-propenyl]- benzoic acid (TTNPB), and
3-methyl-TTNPB, which differ in their specificity towards different RA
receptors, were also active in downregulating TNF receptors.
3-Methyl-TTNPB, which is more specific for the RXR form of the RA receptor,
was found to be most potent. The downregulation of TNF receptors by RA
correlated with the downmodulation of the antiproliferative effects of TNF
against U-937 cells. Overall, our results indicate that RA downmodulates
both the p60 and p80 form of the TNF receptor on cells of myeloid origin,
which correlates with the cellular response.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1995 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||